Real-world discontinuation of hepatitis C drugs was low, but it was 3 times more likely than in clinical trials and varied by patient characteristics.
Jeah Jung, PhD, MPH
Advertisement
Articles by Jeah Jung, PhD, MPH
Advertisement
Latest Updated Articles
- Discontinuation of New Hepatitis C Drugs Among Medicare Patients
Published: February 12th 2020 | Updated:
Advertisement
Advertisement
